Safety and Efficacy of Corona vaccines
8. April 2021
Experiences after the first months of vaccination
Following roll out of the first vaccines against Covid 19 the incoming safety
and efficacy data are of utmost importance due to the limited documentation
available for approval How are the emerging clinical profiles of the different
vaccines? What are the main safety findings in Denmark and abroad? What
are the unknowns? Any specific concerns for children and elderly and for
other groups of people?
Free online seminar:
14.00-14.05
Welcome by Danish Pharmaceutical Society
Stine Harloff Helleberg, Lise Sylvest Helledi and
Steen Ingwersen, Danish Pharmaceutical Society
14.05-14.40
Clinical profiles of covid 19 vaccines
Jens Lundgren
Professor of Infectious Diseases, Rigshospitalet, Denmark.
14.45-15.10
Emerging safety profiles of covid 19 vaccines in Denmark
Tanja Erichsen , Head of Section, Danish Medical Agency
15.15-15.40
Unknowns about the covid 19 vaccines
Christine Stabell Benn
Professor of Global Health, University of Southern Denmark
15.45-16.00
Discussion and wrap up
